Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $25,631 - $29,432
-990 Reduced 7.64%
11,965 $332,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $138,489 - $179,882
-5,300 Reduced 29.03%
12,955 $372,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $116,791 - $152,045
2,965 Added 19.39%
18,255 $744,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $8,350 - $10,900
-200 Reduced 1.29%
15,290 $783,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $34,132 - $41,667
780 Added 5.3%
15,490 $731,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $34,132 - $41,667
780 Added 5.3%
15,490 $731,000
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $8,242 - $10,588
210 Added 1.45%
14,710 $633,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $15,070 - $16,996
-450 Reduced 3.01%
14,500 $525,000
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $17,404 - $22,131
-520 Reduced 3.36%
14,950 $550,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $78,422 - $92,007
2,470 Added 19.0%
15,470 $568,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $120,480 - $146,160
4,000 Added 44.44%
13,000 $425,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $74,683 - $106,707
-2,763 Reduced 23.49%
9,000 $294,000
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $96,147 - $107,952
2,600 Added 28.37%
11,763 $510,000
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $109,139 - $124,430
-2,837 Reduced 23.64%
9,163 $400,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $103,410 - $125,430
3,000 Added 33.33%
12,000 $529,000
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $296,820 - $316,439
9,000 New
9,000 $327,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Marietta Investment Partners LLC Portfolio

Follow Marietta Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marietta Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marietta Investment Partners LLC with notifications on news.